Applied DNA Sciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $1,024 | $565 | $199 | $304 |
Gross Profit | 806 | 266 | -167 | 5 |
EBITDA | -6,644 | -18,557 | -5,926 | -3,569 |
EBIT | -6,665 | -18,606 | -6,054 | -3,647 |
Net Income | -6,665 | -18,593 | -5,271 | -3,945 |
Net Change In Cash | 1,024 | 565 | 199 | 304 |
Free Cash Flow | -2,049 | -5,545 | -3,377 | -2,827 |
Cash | 949 | 2,450 | 1,667 | 4,727 |
Basic Shares | 9,735 | 8,942 | 1,662 | 572 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $2,136 | $3,431 | $13,367 | $18,168 |
Gross Profit | 838 | 1,016 | 5,533 | 5,053 |
EBITDA | -15,256 | -6,391 | -8,660 | -6,979 |
EBIT | -15,640 | -7,088 | -10,022 | -8,270 |
Net Income | -15,160 | -6,992 | -9,947 | -8,267 |
Net Change In Cash | 2,136 | 3,431 | 13,367 | 18,168 |
Free Cash Flow | -12,831 | -14,119 | -6,296 | -9,466 |
Cash | 1,667 | 6,431 | 7,151 | 15,215 |
Basic Shares | 517 | 105 | 17 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.68 |
2025-12-31 | -$2.08 |
2025-06-30 | -$33.42 |
2025-03-31 | -$15.35 |